Gotham Asset Management’s Provention Bio, Inc. Common Stock PRVB Stock Holding History

Gotham Asset Management’s Portfolio PRVB Stock Details PRVB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-49,299	Closed	-$1.19M	–	1458
2023 Q1	$1.19M	Buy	49,299 +17,704	+56%	+$222K	0.03%	696
2022 Q4	$334K	Buy	+31,595	New	+$255K	0.01%	1010

Other funds holding PRVB

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Gotham Asset Management's PRVB Position: Q2 2023 in Review

Gotham Asset Management sold out of Provention Bio, Inc. Common Stock (PRVB) in Q2 2023, closing a stake of 49,299 shares — an estimated $1.19M sold.

Gotham Asset Management first reported a position in PRVB in Q4 2022 and held it in 2 quarters. The position peaked at $1.19M in Q1 2023. 1 fund tracked by Wall St. Rank holds PRVB as of Q2 2023.

Gotham Asset Management reported no remaining Provention Bio, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Gotham Asset Management sold 49,299 Provention Bio, Inc. Common Stock shares in Q2 2023, an estimated $1.19M.
Gotham Asset Management first reported a position in Provention Bio, Inc. Common Stock in Q4 2022 and held it in 2 quarters.
Gotham Asset Management's Provention Bio, Inc. Common Stock position peaked at $1.19M in Q1 2023.
1 fund tracked by Wall St. Rank held Provention Bio, Inc. Common Stock as of Q2 2023.

Based on Gotham Asset Management's 13F filing for Q2 2023, filed 14 Aug 2023.